BDX Stock Analysis: Buy, Sell, or Hold?

BDX - Becton, Dickinson and Co.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$192.00
4.38 (2.33%) ▲
5d: +4.69%
30d: +25.51%
90d: +31.28%
WAIT
LOW Confidence
Protect Your BDX Gains
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026 0d

Get Alerted When BDX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: BDX shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$201.87
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$125.34
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BDX is currently trading at $192.00, which is considered extended relative to its 30-day fair value range of $156.72 to $181.82. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.4) compared to its historical average (12.1). At these levels, the market is pricing in 6.1% annual earnings growth.

Technical Outlook: Technically, BDX is in a strong uptrend. The price is approaching resistance at $192.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: BDX scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $156.72 - $181.82
Company Quality Score 36/100 (SELL)
Volume Confirmation HIGH
Confidence Score 22.4%

Protect Your Profits

BDX is technically overbought (RSI 79). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range (+5.6% above its trading range)
  • BEARISH: Weak technical setup (5/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($194.42)
  • BULLISH: Expecting earnings turnaround to 6.1% growth with 5.4% revenue growth
  • WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $156.72 - $181.82
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $175.63
Resistance Level $192.30
Current Trend Strong Uptrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 14.44
Wall Street Target $194.42 (+1.3%)
Revenue Growth (YoY) 5.4%
Earnings Growth (YoY) -31.4%
Profit Margin 4.2%
Valuation Premium vs History +6.1% premium
PE vs Historical 14.4 vs 12.1 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +6.1% (market-implied from PE analysis)
1-Year Target $203.71 (+6%)
2-Year Target $216.14 (+13%)
3-Year Target $229.32 (+19%)
3-Yr Target (if PE normalizes) (PE: 14→12) PE COMPRESSION $192.10 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.1, Growth: 5.3%) $311.53 (+62%)
Base: (SPY PE: 14.4, Growth: 5.3%) $224.20 (+17%)
Bear: (PE: 12.1, Growth: 5.3%) $187.82 (-2%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 32.46 | Current EPS (TTM): $5.78
Bull Case $412.76 (+115%)
Analyst growth 100.0%, PE expands to 35.7
Base Case $375.24 (+95%)
Market implied 100.0%, PE stable at 32.5
Bear Case $127.58 (-34%)
Severe decline -20.0%, PE contracts to 27.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 22, 2026 1:52 PM ET
Data refreshes hourly during market hours. Next update: 2:52 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna BUY 2026-03-23
Kevin Hern SELL 2026-03-17
Michael Feld SELL 75 shares 2026-02-26

Unlock Insider Activity

See real-time buying/selling by company executives for BDX.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$478 46 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$86 37 SELL
WST
West Pharmaceutical Serv…
STRONG BUY
13 analysts
$405 66 BUY
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$186 45 HOLD
RMD
ResMed Inc
BUY
19 analysts
$247 41 HOLD

Advanced BDX Option Strategies

Professional options setups generated by AI based on today's BDX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BDX

BDX Technical Chart BDX Price Prediction BDX Earnings Date BDX Investment Advisor BDX Fair Price Analyzer BDX Options Advisor BDX Options Chain BDX Options Analysis BDX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals